vTv Therapeutics (VTVT) Long-Term Investments (2017 - 2023)

vTv Therapeutics (VTVT) has 7 years of Long-Term Investments data on file, last reported at $4.4 million in Q3 2023.

• For the quarter ending Q3 2023, Long-Term Investments fell 28.96% year-over-year to $4.4 million; the trailing twelve-month figure through Sep 2023 stood at $4.4 million (down 28.96% YoY), and the FY2022 full-year result was $5.6 million, down 39.08% from the prior year.
• Long-Term Investments slipped to $4.4 million in Q3 2023, from $8.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $9.6 million in Q2 2021 to a low of $2.5 million in Q1 2019.
• A 5-year average of $5.4 million and a median of $5.8 million in 2022 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments surged 287.98% in 2021 and sank 40.01% in 2022, its largest moves.
• Tracing VTVT's Long-Term Investments over 5 years: stood at $2.5 million in 2019, then soared by 171.17% to $6.7 million in 2020, then soared by 36.4% to $9.2 million in 2021, then sank by 39.08% to $5.6 million in 2022, then dropped by 21.49% to $4.4 million in 2023.
• Business Quant data shows VTVT's Long-Term Investments at $4.4 million in Q3 2023, $8.0 million in Q2 2023, and $7.7 million in Q1 2023.